Cargando…

Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India

This was a population based cross-sectional study carried out to estimate and compare the seroprevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in the three largest cities of Odisha, India, and ascertain the association with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kshatri, Jaya Singh, Bhattacharya, Debdutta, Kanungo, Srikanta, Giri, Sidhartha, Palo, Subrata Kumar, Parai, Debaprasad, Turuk, Jyotirmayee, Mansingh, Asit, Choudhary, Hari Ram, Pattnaik, Matrujyoti, Dash, Girish Chandra, Mohanty, Prasantajyoti, Mishra, Niranjan, Satapathy, Durga Madhab, Sahoo, Sanjaya Kumar, Pati, Sanghamitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131641/
https://www.ncbi.nlm.nih.gov/pubmed/34006960
http://dx.doi.org/10.1038/s41598-021-89877-y
_version_ 1783694742289121280
author Kshatri, Jaya Singh
Bhattacharya, Debdutta
Kanungo, Srikanta
Giri, Sidhartha
Palo, Subrata Kumar
Parai, Debaprasad
Turuk, Jyotirmayee
Mansingh, Asit
Choudhary, Hari Ram
Pattnaik, Matrujyoti
Dash, Girish Chandra
Mohanty, Prasantajyoti
Mishra, Niranjan
Satapathy, Durga Madhab
Sahoo, Sanjaya Kumar
Pati, Sanghamitra
author_facet Kshatri, Jaya Singh
Bhattacharya, Debdutta
Kanungo, Srikanta
Giri, Sidhartha
Palo, Subrata Kumar
Parai, Debaprasad
Turuk, Jyotirmayee
Mansingh, Asit
Choudhary, Hari Ram
Pattnaik, Matrujyoti
Dash, Girish Chandra
Mohanty, Prasantajyoti
Mishra, Niranjan
Satapathy, Durga Madhab
Sahoo, Sanjaya Kumar
Pati, Sanghamitra
author_sort Kshatri, Jaya Singh
collection PubMed
description This was a population based cross-sectional study carried out to estimate and compare the seroprevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in the three largest cities of Odisha, India, and ascertain the association with the progression of the epidemic. The survey carried out in August 2020 in the three largest cities of the state of Odisha, India. Blood samples were collected from the residents using random sampling methods and tested for anti- SARS CoV-2 antibodies using an automated CLIA platform. A total of 4146 participants from the 3 cities of Bhubaneswar (BBS), Berhampur (BAM) and Rourkela (RKL) participated. The female to male participation ratio was 5.9:10 across the three cities. The gender weighted seroprevalence across the three cities was 20.78% (95% CI 19.56–22.05%). While females reported a higher seroprevalence (22.8%) as compared to males (18.8%), there was no significant difference in seroprevalence across age groups. A majority of the seropositive participants were asymptomatic (90.49%). The case to infection ratio on the date of serosurvey was 1:6.6 in BBS, 1:61 in BAM and 1:29.8 in RKL. The study found a high seroprevalence against COVID-19 in urban Odisha as well as high numbers of asymptomatic infections. The epidemic curves had a correlation with the seroprevalence.
format Online
Article
Text
id pubmed-8131641
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81316412021-05-25 Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India Kshatri, Jaya Singh Bhattacharya, Debdutta Kanungo, Srikanta Giri, Sidhartha Palo, Subrata Kumar Parai, Debaprasad Turuk, Jyotirmayee Mansingh, Asit Choudhary, Hari Ram Pattnaik, Matrujyoti Dash, Girish Chandra Mohanty, Prasantajyoti Mishra, Niranjan Satapathy, Durga Madhab Sahoo, Sanjaya Kumar Pati, Sanghamitra Sci Rep Article This was a population based cross-sectional study carried out to estimate and compare the seroprevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in the three largest cities of Odisha, India, and ascertain the association with the progression of the epidemic. The survey carried out in August 2020 in the three largest cities of the state of Odisha, India. Blood samples were collected from the residents using random sampling methods and tested for anti- SARS CoV-2 antibodies using an automated CLIA platform. A total of 4146 participants from the 3 cities of Bhubaneswar (BBS), Berhampur (BAM) and Rourkela (RKL) participated. The female to male participation ratio was 5.9:10 across the three cities. The gender weighted seroprevalence across the three cities was 20.78% (95% CI 19.56–22.05%). While females reported a higher seroprevalence (22.8%) as compared to males (18.8%), there was no significant difference in seroprevalence across age groups. A majority of the seropositive participants were asymptomatic (90.49%). The case to infection ratio on the date of serosurvey was 1:6.6 in BBS, 1:61 in BAM and 1:29.8 in RKL. The study found a high seroprevalence against COVID-19 in urban Odisha as well as high numbers of asymptomatic infections. The epidemic curves had a correlation with the seroprevalence. Nature Publishing Group UK 2021-05-18 /pmc/articles/PMC8131641/ /pubmed/34006960 http://dx.doi.org/10.1038/s41598-021-89877-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kshatri, Jaya Singh
Bhattacharya, Debdutta
Kanungo, Srikanta
Giri, Sidhartha
Palo, Subrata Kumar
Parai, Debaprasad
Turuk, Jyotirmayee
Mansingh, Asit
Choudhary, Hari Ram
Pattnaik, Matrujyoti
Dash, Girish Chandra
Mohanty, Prasantajyoti
Mishra, Niranjan
Satapathy, Durga Madhab
Sahoo, Sanjaya Kumar
Pati, Sanghamitra
Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
title Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
title_full Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
title_fullStr Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
title_full_unstemmed Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
title_short Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
title_sort serological surveys to inform sars-cov-2 epidemic curve: a cross-sectional study from odisha, india
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131641/
https://www.ncbi.nlm.nih.gov/pubmed/34006960
http://dx.doi.org/10.1038/s41598-021-89877-y
work_keys_str_mv AT kshatrijayasingh serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT bhattacharyadebdutta serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT kanungosrikanta serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT girisidhartha serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT palosubratakumar serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT paraidebaprasad serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT turukjyotirmayee serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT mansinghasit serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT choudharyhariram serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT pattnaikmatrujyoti serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT dashgirishchandra serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT mohantyprasantajyoti serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT mishraniranjan serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT satapathydurgamadhab serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT sahoosanjayakumar serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT patisanghamitra serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia
AT serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia